Next Generation Cancer Diagnostics Market 2025 to 2034
Next Generation Cancer Diagnostics Market 2025 to 2034
Next Generation Cancer Diagnostics Market (By Technology: Next-generation Sequencing, Lab-on-a-chip (LOAC) & RT-PCR, qPCR & Multiplexing, Protein Microarrays, DNA Microarrays; By Application: Biomarker Development, Proteomic Analysis, CTC Analysis, Epigenetic Analysis, Genetic Analysis; By Cancer Type; By Function; By Region: North America, Latin America, Europe, Asia-Pacific, Middle and East Africa) Industry Size, Share, Growth, Trends 2025 to 2034.
Customisation Request
Revenue, 2025
USD 19.16 Bn
Forecast Year, 2034
USD 38.36 Bn
CAGR, 2025 - 2034
8.02%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global next-generation cancer diagnostics market, valued at USD 19.16B in 2025, is projected to reach USD 38.36B by 2034, growing at a CAGR of 8.02%, driven by advances in precision diagnostics and early cancer detection technologies.
Next Generation Cancer Diagnostics Market Size Analysis
Next Generation Cancer Diagnostics Market Size By Technology 2025 to 2034 (USD Billion)
| Technology | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| DNA Microarrays | 1.99 | 2.15 | 2.32 | 2.51 | 2.71 | 2.93 | 3.16 | 3.42 | 3.69 | 3.99 |
| Protein Microarrays | 2.75 | 2.97 | 3.21 | 3.46 | 3.74 | 4.04 | 4.36 | 4.71 | 5.09 | 5.50 |
| qPCR & Multiplexing | 3.48 | 3.76 | 4.06 | 4.39 | 4.74 | 5.12 | 5.53 | 5.97 | 6.45 | 6.97 |
| Lab-on-a-chip (LOAC) & RT-PCR | 4.19 | 4.53 | 4.89 | 5.28 | 5.70 | 6.16 | 6.66 | 7.19 | 7.77 | 8.39 |
| Next-generation Sequencing | 6.75 | 7.29 | 7.88 | 8.51 | 9.19 | 9.93 | 10.73 | 11.59 | 12.51 | 13.52 |
Next Generation Cancer Diagnostics Market Size By Application 2025 to 2034 (USD Billion)
| Application | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| CTC Analysis | 3.08 | 3.32 | 3.59 | 3.88 | 4.19 | 4.52 | 4.89 | 5.28 | 5.70 | 6.16 |
| Epigenetic Analysis | 3.32 | 3.58 | 3.87 | 4.18 | 4.52 | 4.88 | 5.27 | 5.69 | 6.15 | 6.64 |
| Genetic Analysis | 3.76 | 4.06 | 4.39 | 4.74 | 5.12 | 5.53 | 5.98 | 6.45 | 6.97 | 7.53 |
| Proteomic Analysis | 3.79 | 4.09 | 4.42 | 4.77 | 5.16 | 5.57 | 6.02 | 6.50 | 7.02 | 7.58 |
| Biomarker Development | 5.22 | 5.64 | 6.09 | 6.58 | 7.11 | 7.68 | 8.29 | 8.96 | 9.68 | 10.45 |
Next Generation Cancer Diagnostics Market Size By Cancer Type 2025 to 2034 (USD Billion)
| Cancer Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Others | 2.38 | 2.57 | 2.78 | 3.00 | 3.24 | 3.50 | 3.79 | 4.09 | 4.42 | 4.77 |
| Cervical Cancer | 2.74 | 2.96 | 3.20 | 3.45 | 3.73 | 4.03 | 4.35 | 4.70 | 5.08 | 5.49 |
| Colorectal Cancer | 3.99 | 4.31 | 4.65 | 5.03 | 5.43 | 5.86 | 6.34 | 6.84 | 7.39 | 7.98 |
| Breast Cancer | 4.63 | 5.00 | 5.40 | 5.83 | 6.30 | 6.80 | 7.35 | 7.94 | 8.58 | 9.26 |
| Lung Cancer | 5.42 | 5.86 | 6.33 | 6.84 | 7.38 | 7.98 | 8.62 | 9.31 | 10.05 | 10.86 |
Next Generation Cancer Diagnostics Market Size By Function 2025 to 2034 (USD Billion)
| Function | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Risk Analysis | 2.97 | 3.20 | 3.46 | 3.74 | 4.04 | 4.36 | 4.71 | 5.09 | 5.50 | 5.94 |
| Prognostics | 3.40 | 3.68 | 3.97 | 4.29 | 4.64 | 5.01 | 5.41 | 5.84 | 6.31 | 6.82 |
| Cancer Screening | 4.09 | 4.42 | 4.78 | 5.16 | 5.57 | 6.02 | 6.50 | 7.02 | 7.59 | 8.20 |
| Companion Diagnostics | 4.22 | 4.56 | 4.93 | 5.32 | 5.75 | 6.21 | 6.71 | 7.25 | 7.83 | 8.46 |
| Therapeutic Monitoring | 4.47 | 4.83 | 5.22 | 5.63 | 6.09 | 6.57 | 7.10 | 7.67 | 8.29 | 8.95 |
Next Generation Cancer Diagnostics Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Middle East and Africa | 1.00 | 1.08 | 1.17 | 1.26 | 1.36 | 1.47 | 1.59 | 1.72 | 1.85 | 2.00 |
| Latin America | 1.38 | 1.49 | 1.61 | 1.74 | 1.88 | 2.03 | 2.19 | 2.37 | 2.56 | 2.76 |
| Asia Pacific | 4.66 | 5.03 | 5.43 | 5.87 | 6.34 | 6.85 | 7.40 | 7.99 | 8.63 | 9.33 |
| Europe | 4.97 | 5.37 | 5.80 | 6.26 | 6.77 | 7.31 | 7.90 | 8.53 | 9.21 | 9.95 |
| North America | 7.15 | 7.73 | 8.35 | 9.02 | 9.74 | 10.52 | 11.36 | 12.28 | 13.26 | 14.32 |
Next Generation Cancer Diagnostics Market Size to Lead USD 38.36 Billion by 2034
The global next generation cancer diagnostics market size was evaluated at USD 19.16 billion in 2025 and is expected to grow around USD 38.36 billion by 2034 a CAGR of 8.02%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
